Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
BIBF 1000 is a small molecule inhibitor targeting the receptor kinases of platelet-derived growth factor (PDGF), basic fibroblast growth factor and vascular endothelial growth factor, which have known roles in the pathogenesis of pulmonary fibrosis. The anti-fibrotic potential of BIBF 1000 was determined in a rat model of bleomycin-induced lung fibrosis and in an ex vivo fibroblast differentiation assay. Rats exposed to a single intra-tracheal injection of bleomycin were treated with BIBF 1000 starting 10 days after bleomycin administration. To gauge for anti-fibrotic activity, collagen deposition and pro-fibrotic growth factor gene expression was analysed in isolated lungs. Furthermore, the activity of BIBF 1000 was compared with imatinib mesylate (combined PDGF receptor, c-kit and c-abl kinase inhibitor) and SB-431542 (transforming growth factor (TGF)-β receptor I kinase inhibitor) in an ex vivo TGF-β-driven fibroblast to myofibroblast differentiation assay, performed in primary human bronchial fibroblasts. Treatment of rats with BIBF 1000 resulted in the attenuation of fibrosis as assessed by the reduction of collagen deposition and the inhibition of pro-fibrotic gene expression. In the cellular assay both SB-431542 and BIBF 1000 showed dose-dependent inhibition of TGF-β-induced differentiation, whereas imatinib mesylate was inactive. BIBF 1000, or related small molecules with a similar kinase inhibition profile, may represent a novel therapeutic approach for the treatment of idiopathic pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS
Roche, W., Williams, J., Beasley, R., & Holgate, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90067-6 · Cited by 1,120
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., & Klagsbrun, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2292 · Cited by 1,032
Remodeling in Asthma and Chronic Obstructive Lung Disease
JEFFERY, P. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.supplement_2.2106061 · Cited by 917
TGF-β signaling: positive and negative effects on tumorigenesis
Wakefield, L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Myofibroblasts and Subepithelial Fibrosis in Bronchial Asthma
Brewster, C. E. P., Howarth, P. H., Djukanovic, R., Wilson, J., Holgate, S. T., & Roche, W. R. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/3.5.507 · Cited by 663
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19603 · Cited by 574
Epithelial-mesenchymal interactions in the pathogenesis of asthma
Holgate, S. T., Davies, D. E., Lackie, P. M., Wilson, S. J., Puddicombe, S. M., & Lordan, J. L. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90066-6 · Cited by 514
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Self-citationTGF-β is a critical mediator of acute lung injury
Pittet, J.-F., Griffiths, M. J. D., Geiser, T., Kaminski, N., Dalton, S. L., Huang, X., Brown, L. A. S., Gotwals, P. J., Koteliansky, V. E., Matthay, M. A., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11963 · Cited by 487
Hoshino, M., Takahashi, M., & Aoike, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.111928 · Cited by 423
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · Apoptosis · doi:10.1007/s10495-005-1055-4 · Cited by 419
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., & Wakefield, L. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318899 · Cited by 393
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Abdollahi, A., Li, M., Ping, G., Plathow, C., Domhan, S., Kiessling, F., Lee, L. B., McMahon, G., Gröne, H.-J., Lipson, K. E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041393 · Cited by 388
Ramos, C., Montaño, M., Garcı́a-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., & Pardo, A. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4333 · Cited by 363
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model
Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 358
Self-citationCoker, R. K., Laurent, G. J., Shahzeidi, S., Lympany, P. A., du Bois, R. M., Jeffery, P. K., & McAnulty, R. J. (1997) · Europe PMC (PubMed Central) · Cited by 292
Lung cancer in patients with idiopathic pulmonary fibrosis
Park, J., Kim, D. S., Shim, T. S., Lim, C.-M., Koh, Y., Lee, S. D., Kim, W. S., Kim, W. D., Lee, J. S., & Song, K. S. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99055301 · Cited by 267
Self-citationRichter, A., Puddicombe, S. M., Lordan, J. L., Bucchieri, F., Wilson, S. J., Djukanović, R., Dent, G., Holgate, S. T., & Davies, D. E. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4437 · Cited by 266
Bonniaud, P., Margetts, P. J., Kolb, M., Schroeder, J. A., Kapoun, A. M., Damm, D., Murphy, A., Chakravarty, S., Dugar, S., Higgins, L., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-612oc · Cited by 256
Chambers, R. C., Leoni, P., Kaminski, N., Laurent, G. J., & Heller, R. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63847-3 · Cited by 255
Pigment Epithelium–derived Factor in Idiopathic Pulmonary Fibrosis: A Role in Aberrant Angiogenesis
Cosgrove, G. P., Brown, K. K., Schiemann, W. P., Serls, A. E., Parr, J. E., Geraci, M. W., Schwarz, M. I., Cool, C. D., & Worthen, G. S. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1151oc · Cited by 253
Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis
Lasky, J. A., Ortiz, L. A., Tonthat, B., Hoyle, G. W., Corti, M., Athas, G., Lungarella, G., Brody, A., & Friedman, M. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.2.l365 · Cited by 247
Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved
Guyot, C., Lepreux, S., Combe, C., Doudnikoff, E., Bioulac-Sage, P., Balabaud, C., & Desmoulière, A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.021 · Cited by 243
Precapillary Systemic-pulmonary Anastomoses
Turner-Warwick, M. (1963) · Thorax · doi:10.1136/thx.18.3.225 · Cited by 240
Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice
Aono, Y., Nishioka, Y., Inayama, M., Ugai, M., Kishi, J., Uehara, H., Izumi, K., & Sone, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-531oc · Cited by 231
HASHIMOTO, S., GON, Y., TAKESHITA, I., MATSUMOTO, K., MARUOKA, S., & HORIE, T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2005069 · Cited by 228
Zhang, S., Smartt, H. J. M., Holgate, S. T., & Roche, W. R. (1999) · PubMed · Cited by 218
Howell, D. C. J., Goldsack, N. R., Marshall, R. P., McAnulty, R. J., Starke, R., Purdy, G., Laurent, G. J., & Chambers, R. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62525-4 · Cited by 186
Hetzel, M., Bachem, M., Anders, D., Trischler, G., & Faehling, M. (2005) · Lung · doi:10.1007/s00408-004-2534-z · Cited by 186
The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma
Holgate, S. T., Lackie, P. M., Davies, D. E., Roche, W. R., & Walls, A. F. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00016.x · Cited by 182
Khalil, N., Xu, Y. D., O'Connor, R., & Duronio, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510441200 · Cited by 182
Crystal, R. G., Bitterman, P. B., Mossman, B., Schwarz, M. I., Sheppard, D., Almasy, L., Chapman, H. A., Friedman, S. L., King, T. E., Leinwand, L. A., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201069 · Cited by 181
Santiago, B., Gutierrez-Cañas, I., Dotor, J., Palao, G., Lasarte, J. J., Ruiz, J., Prieto, J., Borrás-Cuesta, F., & Pablos, J. L. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23859.x · Cited by 171
Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice
Hamada, N., Kuwano, K., Yamada, M., Hagimoto, N., Hiasa, K., Egashira, K., Nakashima, N., Maeyama, T., Yoshimi, M., & Nakanishi, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1224 · Cited by 170
Matsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shimizu, K., Aburatani, H., Mishima, H. K., Imamura, T., Miyazono, K., et al. (2003) · PubMed · Cited by 158
The renal cortical fibroblast in renal tubulointerstitial fibrosis
Qi, W., Chen, X., Poronnik, P., & Pollock, C. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.09.005 · Cited by 143
Uhal, B. D., Joshi, I., True, A. L., Mundle, S., Raza, A., Pardo, A., & Selman, M. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.269.6.l819 · Cited by 142
Battegay, E. J., Raines, E. W., Colbert, T., & Ross, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.6040 · Cited by 119
Roles for Insulin-Like Growth Factor I and Transforming Growth Factor-β in Fibrotic Lung Disease*
Krein, P. M., & Winston, B. W. (2002) · CHEST Journal · doi:10.1378/chest.122.6_suppl.289s · Cited by 119
PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases
Levitzki, A. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.010 · Cited by 94
Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo.
Yi, E. S., Lee, H., Yin, S., Piguet, P. F., Sarosi, I., Kaufmann, S., Tarpley, J. E., Wang, N. S., & Ulich, T. R. (1996) · Europe PMC (PubMed Central) · Cited by 85
McAnulty, R. J., Campa, J. S., Cambrey, A. D., & Laurent, G. J. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90066-7 · Cited by 82
Li, Y. J., Azuma, A., Usuki, J., Abe, S., Matsuda, K., Sunazuka, T., Shimizu, T., Hirata, Y., Inagaki, H., Kawada, T., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-16 · Cited by 78
Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis
Zhuo, Y., Zhang, J., Laboy, M., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00083.2003 · Cited by 73
Idiopathic Pulmonary Fibrosis in Patients Younger Than 50 Years
Nadrous, H. F., Myers, J. L., Decker, P. A., & Ryu, J. H. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62955-8 · Cited by 66
Lappi‐Blanco, E., Soini, Y., Kinnula, V. L., & Pääkkö, P. K. (2001) · The Journal of Pathology · doi:10.1002/path.1038 · Cited by 66
Johnson, L. R. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.4.c819 · Cited by 57
Angiogenesis and Pulmonary Fibrosis
Keane, M. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2405007 · Cited by 46
Bisping, G., Kropff, M. H., Wenning, D., Dreyer, B., Bessonov, S., Hilberg, F., Roth, G. J., Munzert, G. M., Štefanič, M., Stelljes, M., et al. (2005) · Blood · doi:10.1182/blood-2004-11-4250 · Cited by 37
Self-citationTGF-βbgr;1 stimulates the release of pre-formed bFGF from renal proximal tubular cells
Jones, S. G., Morrisey, K., Williams, J. D., & Phillips, A. O. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00517.x · Cited by 36
Fehrenbach, H., Haase, M., Kasper, M. E., Koslowski, R., Schuh, D., & Müller, M. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050390 · Cited by 33
Inhibition of ALK5 as a New Approach to Treat Liver Fibrotic Diseases
de Gouville, A., & Huet, S. (2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.2.977444 · Cited by 30
An ex vivo model for functional studies of myofibroblasts
Kilarski, W. W., Jura, N., & Gerwins, P. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700255 · Cited by 26
Cited by
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056
“As this pathologic condition is strongly linked to PDGF rather than VEGF signaling (36),(3) these data independently confirm that BIBF 1120 is an effective PDGF signaling inhibitor in vivo .”
BackgroundSelf-citation
Metadata
- Authors
- Chaudhary, N. I., Roth, G. J., Hilberg, F., Müller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., & Park, J. E.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2007-02-14
- Volume
- 29
- Issue
- 5
- Pages
- 976-985
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2115141581
- Cited by
- 386
- References
- 61
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.